Testing Federal Healthcare Laws: Risks In Genetic Testing Programs

DOJ Signals Continued Robust Enforcement of the False Claims Act In the New Administration

Congressional Investigations Outlook: What to Expect from the 119th Congress

2024 Healthcare Fraud Enforcement Year in Review

New HHS-OIG Guidance on Sponsored Genetic-Testing Programs

DOJ Announces $2.92 Billion in False Claims Act Recoveries in Fiscal Year 2024

Privacy + Data Security Predictions for 2025

Ask A Mentor: Is Secondment A Good Career Move?

When Your Life Sciences Are on the Line: Protecting Your Company’s Most Valuable Asset: Trade Secrets

DOJ Releases 2024 COVID-19 Fraud Enforcement Task Force Report

Artificial Intelligence in Healthcare: New Avenues for Liability

Deputy Attorney General Lisa Monaco Announces DOJ’s Approach to AI

2024 Regulatory, Compliance, and Enforcement Predictions for Life Sciences Companies

Symbiosis through secondment: A practical guide

The Sixth Circuit Narrows the Scope of AKS and FCA Liability